Literature DB >> 15481442

Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome.

Xiao Li1, C Eileen Bryant, H Joachim Deeg.   

Abstract

Bone marrow samples from 18 patients with myelodysplastic syndrome (MDS) with clonal cytogenetic abnormalities were characterized by combining fluorescence in situ hybridization (FISH) with in situ end-labeling (ISEL) or with annexin V staining and flow cytometry (AV/FLOW) to determine the clonal nature of hematopoietic cells undergoing apoptosis in marrow cells. Apoptosis occurred in both normal and clonal cells. However, the proportion of clonal cells identified by FISH among apoptotic cells was lower than the proportion among nonclonal cells in 17 of 18 patients, regardless of whether ISEL or AV/ FLOW was used to identify apoptosis. This technique allows us to identify simultaneously clonality (as determined by FISH) and apoptosis in individual cells and shows that although apoptosis occurs predominantly in residual normal (FISH-negative) cells, a proportion of clonal precursors in MDS marrow also die from programmed cell death. Such a mechanism may be responsible for the generally slow expansion of the clone in MDS.

Entities:  

Mesh:

Year:  2004        PMID: 15481442     DOI: 10.1532/ijh97.na0402

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Apoptosis in maternal peripheral blood during pregnancy.

Authors:  A Kolialexi; G T Tsangaris; A Antsaklis; F Tzortzatou; C Amentas; A Koratzis; A Mavrou
Journal:  Fetal Diagn Ther       Date:  2001 Jan-Feb       Impact factor: 2.587

2.  Apoptosis in fetal nucleated erythrocytes circulating in maternal blood.

Authors:  A Sekizawa; O Samura; D K Zhen; V Falco; A Farina; D W Bianchi
Journal:  Prenat Diagn       Date:  2000-11       Impact factor: 3.050

3.  The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.

Authors:  S Mundle; P Venugopal; V Shetty; A Ali; H Chopra; H Handa; S Rose; B Y Mativi; S A Gregory; H D Preisler; A Raza
Journal:  Int J Hematol       Date:  1999-04       Impact factor: 2.490

4.  Apoptosis in bone marrow of myelodysplastic syndrome patients.

Authors:  A D Bogdanović; G M Janković; M D Colović; D P Trpinać; V Z Bumbasirević
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

Review 5.  Myelodysplastic syndrome: review of the cytogenetic and molecular data.

Authors:  P Mhawech; A Saleem
Journal:  Crit Rev Oncol Hematol       Date:  2001-12       Impact factor: 6.312

Review 6.  Excessive apoptosis in low risk myelodysplastic syndromes (MDS).

Authors:  J E Parker; G J Mufti
Journal:  Leuk Lymphoma       Date:  2000-12

7.  [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].

Authors:  Xiao Li; Quan Pu; Yizhi Liu; Jun Shi; Ying Tao; Chunkang Chang; Qinyan Jiang; Wei Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2002-01

8.  Proposals for the classification of the myelodysplastic syndromes.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1982-06       Impact factor: 6.998

9.  A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.

Authors:  G M Gersuk; C Beckham; M R Loken; P Kiener; J E Anderson; A Farrand; A B Troutt; J A Ledbetter; H J Deeg
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

10.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

Authors:  J Maciejewski; C Selleri; S Anderson; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

View more
  17 in total

1.  The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.

Authors:  Xiang Li; A Mario Marcondes; Theodore A Gooley; H Joachim Deeg
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

2.  NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).

Authors:  Daniella M B Kerbauy; Vladimir Lesnikov; Nissa Abbasi; Sudeshna Seal; Bart Scott; H Joachim Deeg
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

3.  Ras-proximate-1 GTPase-activating protein and Rac2 may play pivotal roles in the initial development of myelodysplastic syndrome.

Authors:  Xuejun Shao; Meihua Miao; Xiaofei Qi; Zixing Chen
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

4.  Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.

Authors:  A Mario Marcondes; Andrew J Mhyre; Derek L Stirewalt; Soo-Hyun Kim; Charles A Dinarello; H Joachim Deeg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

5.  Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression.

Authors:  Merav Bar; Derek Stirewalt; Era Pogosova-Agadjanyan; Vitas Wagner; Ted Gooley; Nissa Abbasi; Ravi Bhatia; H Joachim Deeg; Jerald Radich
Journal:  Transl Oncogenomics       Date:  2008-05-29

6.  Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.

Authors:  Xiang Li; Feng Xu; ChunKang Chang; John Byon; Thalia Papayannopoulou; H Joachim Deeg; A Mario Marcondes
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

7.  Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.

Authors:  Daniel T Starczynowski; Florian Kuchenbauer; Bob Argiropoulos; Sandy Sung; Ryan Morin; Andrew Muranyi; Martin Hirst; Donna Hogge; Marco Marra; Richard A Wells; Rena Buckstein; Wan Lam; R Keith Humphries; Aly Karsan
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

8.  Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.

Authors:  A Mario Marcondes; Xiang Li; Ted A Gooley; Brian Milless; H Joachim Deeg
Journal:  Blood       Date:  2010-01-08       Impact factor: 22.113

Review 9.  Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.

Authors:  Daniella B Kerbauy; H Joachim Deeg
Journal:  Exp Hematol       Date:  2007-11       Impact factor: 3.084

10.  Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.

Authors:  Andrew J Mhyre; A Mario Marcondes; Emily Y Spaulding; H Joachim Deeg
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.